Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PIGT | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | SUMO2 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | UBE2I | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
mRNA | DESI2 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
mRNA | PHF14 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | RNF181 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
mRNA | SNW1 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | RPL6 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | TIMM44 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | RP1-37E16.12 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |